2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$18.48+$0.03 (+0.17%)
Price as of Oct 22, 2026 7:56 PM EDT- $21.2BMarket Cap
- 83.52%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$18.48+$0.03 (+0.17%)
VTRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.45 | ||
Change | -$0.20 (-1.07%) | ||
Open | $18.64 | ||
High | $18.70 | ||
Low | $18.43 | ||
Previous Close | $18.65 | ||
Volume | 10,188,700 | ||
30-Day Average Volume | 9,506,454 | ||
1-Week Change | 5.79% | ||
1-Month Change | 7.89% | ||
1-Year Change | 83.52% | ||
3-Year Change | 125.03% | ||
5-Year Change | 62.52% | ||
Fundamentals | |||
Shares Outstanding | 1.1B | ||
Total Assets | $35.0B | ||
Market Cap | $21.2B | ||
Enterprise Value | $33.7B | ||
Period: QTR TTM FY | |||
Revenue | $3.8B | ||
Net Income | -$118.8M | ||
Free Cash Flow | $329.0M | ||
EBIT | $56.7M | ||
EBITDA | $729.0M | ||
Net Working Capital | $3.7B | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | 46 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | -185 | ||
PEG | 1 | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.60% | ||
Trailing Annual Dividend Yield | 2.60% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield